Ronald DePinho News
Most Popular Ronald DePinho Story
Study: Treat brain tumors with drug combos
Ronald DePinho, MD, director of the Center for Applied Cancer Science at the Dana-Farber Cancer Institute, says that using three or more kinase-blocking therapies like Gleevec and Tarceva in... Read more...
Latest Headlines
- September 18, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
